Rising Pharma Holdings, Inc. Recalls

2 recalls found for Rising Pharma Holdings, Inc.. Check if any of your products are affected.

Health & Personal Care
HIGH
FDA DRUG

Rising Pharmaceuticals Recalls Furosemide Tablets for Contamination Risk

Rising Pharmaceuticals recalled 4,212 bottles of Furosemide Tablets on January 10, 2026. The recall stems from the discovery of a foreign substance in the medication. Consumers should stop using the product immediately and seek guidance from their healthcare provider.

FUROSEMIDE
Presence of
Read more
Health & Personal Care
HIGH
FDA DRUG

Graviti Pharmaceuticals Bupropion Hydrochloride XL 300 mg Recall Impacts 46,512 Bottles (2025)

Graviti Pharmaceuticals Private Limited manufactured Bupropion Hydrochloride Extended-Release Tablets XL 300 mg, distributed nationwide by Rising Pharma Holdings, Inc., in 46,512 bottles. The recall cites failed tablet specifications. Stop using the product immediately and contact the manufacturer or your healthcare provider for guidance.

Bupropion Hydrochloride
Failed Tablet/Capsule
Read more

Brand Statistics

Total Recalls
2
Pages
1

Related Brands

FUROSEMIDEBupropion Hydrochloride